Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 21709220.
- Also identified by DOI 10.1073/pnas.1104104108 and PMC identifier 3136330.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The MHC class I antigen presentation pathway allows the immune system to distinguish between self and nonself. Despite extensive research on the processing of antigenic peptides, little is known about their origin. Here, we show that mRNAs carrying premature stop codons that prevent the production of full-length proteins via the nonsense-mediated decay pathway still produce a majority of peptide substrates for the MHC class I pathway by a noncanonical mRNA translation process. Blocking the interaction of the translation initiation factor eIF4E with the cap structure suppresses the synthesis of full-length proteins but has only a limited effect on the production of antigenic peptides. These results reveal an essential cell biological function for a class of translation products derived during the pioneer round of mRNA translation and will have important implications for understanding how the immune system detects cells harboring pathogens and generates tolerance.
Medical subject headings
- Antigen Presentation
- Histocompatibility Antigens Class I
- RNA, Messenger